Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine gel capsules vs tablets in post-thyroidectomy thyroid cancer
NCT02946918Phase 4Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2017
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levothyroxine sodium in differentiated thyroid cancer (DTC), hypothyroidism, sponsored by UT Southwestern Medical Center. Started Feb 2017; status: terminated.
02
Drugs
levothyroxine sodium
03
Conditions
differentiated thyroid cancer (DTC)hypothyroidism
Beyond the preview
Go deeper on NCT02946918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02946918.